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ABSTRACT
Electrical stimulation of the hypothalamus produces cardiovascular adjustments consisting of hypertension,
tachycardia, visceral vasoconstriction and hindlimb vasodilation. Previous studies have demonstrated that
hindlimb vasodilation is due a reduction of sympathetic vasoconstrictor tone and to activation ofβ2-adrenergic
receptors by catecholamine release. However, the existence of a yet unidentiﬁed vasodilator mechanism has
also been proposed. Recent studies have suggested that nitric oxide (NO) may be involved. The aim of the
present study was to investigate the role of NO in the hindquarter vasodilation in response to hypothalamic
stimulation. In pentobarbital-anesthetized rats hypothalamic stimulation (100 Hz, 150µA, 6 s) produced
hypertension, tachycardia, hindquarter vasodilation and mesenteric vasoconstriction. Alpha-adrenoceptor
blockade with phentolamine (1.5 mg/kg, iv) plus bilateral adrenalectomy did not modify hypertension, tachy-
cardia or mesenteric vasoconstriction induced by hypothalamic stimulation. Hindquarter vasodilation was
strongly reduced but not abolished. The remaining vasodilation was completely abolished after iv injection
of the NOS inhibitor L-NAME (20 mg/kg, iv). To properly evaluate the role of the mechanism of NO in
hindquarter vasodilation, in a second group of animals L-NAME was administered before α-adrenoceptor
blockade plus adrenalectomy. L-NAME treatment strongly reduced hindquarter vasodilation in magnitude
and duration. These results suggest that NO is involved in the hindquarter vasodilation produced by hypotha-
lamic stimulation.
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INTRODUCTION
Defense reactions are a broad class of behaviors
observed in numerous mammalian species, includ-
ing man (Azevedo et al. 1980, Smith and Woodruff
1980, Bolme et al. 1967) and comprise species-
distinctive adjustments both in motor and neuroveg-
etative output (Abrahams et al. 1964, Feigl et al.
1964, Hilton and Zbrozyna 1963, Abrahams et al.
*Member Academia Brasileira de Ciências
Correspondence to: Marcos L. Ferreira-Neto
E-mail: marcosneto@fcr.epm.br
1960a, Eliasson et al. 1951). The neurovegetative
adjustments include cardiovascular, respiratory and
endocrine changes that support the increased
metabolic demand during ﬁght or ﬂight responses.
Cardiovascular adjustments seen during de-
fense reactions include hypertension, tachycardia
and muscle vasodilation. Since the defense reaction
generally involves intense motor activation, muscle
vasodilation is regarded as a key feature of these
responses. However, the mechanisms and central
pathways involved in this vasodilation remain un-
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clear. At least three different mechanisms have been
proposed: a. reduced sympathetic vasoconstrictor
drive; b. release of catecholamines by the adrenal
medulla, and c. activation of a sympathetic vasodila-
tor system.
Whereas in the dog and cat the existence of a
cholinergic sympathetic vasodilator system is well
established (Timms 1981, Schramm et al. 1971,
Bolme et al. 1967, Abrahams et al. 1960a, b),
there is no evidence for such a mechanism in others
species including the rabbit, the monkey and the rat.
Recently, several lines of evidence have sug-
gested that nitric oxide (NO) and/or nitrosylated
factors (NOFs) may act as neurotransmitters
involved in hindlimb vasodilation. First, the lumbar
sympathetic chain contains postganglionic sympa-
thetic ﬁbers immunopositive for nitric oxide syn-
thase (NOS) (Davisson et al. 1994). Second electri-
cal stimulation of post-ganglionic ﬁbers in the lum-
bar sympathetic chain produces hindlimb vasodila-
tion that is dependent on NO synthesis (Davisson et
al. 1997). Third, these ﬁbers may be involved in
the hindlimb vasodilation observed in responses to
baroreceptor stimulation (Possas and Lewis 1997).
They may also be involved in defense reactions
elicited by air jet stress (Davisson et al. 1994).
Therefore in the present study we sought to
investigate the possible role of NO during the
hindlimb vasodilation induced by electrical stimu-
lation of hypothalamic sites in anesthetized rats.
MATERIALSAND METHODS
General Procedures
MaleWistar rats (250-350 g body wt) were obtained
from the central animal house of the Universidade
Federal de São Paulo – Escola Paulista de Medici-
na. All protocols describe here were approved by
the Medical Ethics Committee of the Universidade
Federal de São Paulo.
Anesthesia was induced with 2% halothane in
100% O2 and catheters were placed into the right
carotid artery and jugular vein for measurement of
arterial blood pressure and heart rate and admin-
istration of drugs, respectively. Once the venous
catheter was in place, the animals were anesthetized
with pentobarbital sodium (40 mg/kg iv). The anes-
thetic was supplemented (4 mg/kg iv) every 30 min
for the remainder of the experiment. The arterial
catheter was connected to a pressure transducer at-
tached to a bridge ampliﬁer (ETH-200, CB Sci-
ences, Inc) to record arterial pressure. Pulsatile
(AP) and mean (MAP) arterial blood pressure, heart
rate (HR), mesenteric (MBF) and hindquarter blood
ﬂows (HQBF) were recorded continuously with a
PowerLab system (ADInstruments). Heart rate was
determined from the AP signal. The trachea was
cannulated to reduce airway resistance, and the rats
were mounted prone in a stereotaxic apparatus
(David Kopf Instruments) with the bite bar set
3.4 mm below the interaural line. Infusion (1 ml/hr)
of bicarbonate, dextrose and dextran in saline
(Quintin et al. 1989) was maintained throughout
the experiment. Body temperature was maintained
at 37 ± 0.5◦C with a thermostatically controlled
heating table.
Blood Flow Recording: Miniature pulsed Doppler
ﬂow probes (Haywood et al. 1981) were placed on
the superior mesenteric artery and the inferior ab-
dominal aorta for the measurement of mesenteric
and hindquarter blood ﬂows and for the determina-
tion of vascular conductance.
Hypothalamic Stimulation (HS): A dorsal cran-
iotomy was performed and a Teﬂon-coated tung-
sten microelectrode advanced to the hypothalamus.
Stimulation sites were located within 3.3 to 4.3 mm
caudal, 1.5 mm lateral, and 7.5 to 8.5 mm ventral in
relation to the bregma (Paxinos and Watson 1986),
a region corresponding to the defense area in the rat
(Tan and Dampney 1983, Yardley and Hilton 1986,
1987). The hypothalamus was electrically stimu-
lated for 6 secondswith cathodal squarewave pulses
(150 µA, 0.5 ms, 100 Hz) obtained from a Grass
S88 stimulator through a PSIU6 isolation unit. Suf-
ﬁcient time (≥ 10min)was allowed between stimuli
to permit the hemodynamic parameters to return to
control values.
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Adrenalectomy: The adrenal glands were accessed
through left and right retroperitoneal approaches.
The glands were freed from surrounding tissue and
removed after the adrenal arteries and veins had
been ligated.
Histology: Electrolytic lesions (1 mA DC for 15 s)
were made in the hypothalamus at the end of all
experiments; the animals were perfused transcar-
dially with 10% formalin and the brains were re-
moved. The hypothalamus was cut coronally into
40 µm thick sections and stained with 1% neutral
red. Sections containing the lesion were examined
and plotted on drawings adapted from a rat stereo-
taxic atlas (Paxinos and Watson 1986) with the aid
of a camera lucida attachment (Nikon). A typical
site of hypothalamic stimulation is shown in Fig. 1.
-3.3 mm
-3.8 mm
Fig. 1 – Distribution of stimulation sites in the hypothalamus
(triangles): Abbreviations: mt, mammillothalamic tract; 3V, 3rd
ventricle; f, fornix; DM, dorsomedial hypoth. nu.; VM, ventro-
medial hypoth. nu.; PH, posterior hypothalamus area. Numbers
to the left of each diagram represent the approximate distance
posterior to the bregma.
Drugs: The drugs used were phentolamine
(1.5 mg/kg, iv) and Nω-nitro-L-arginine methyl es-
ter (L-NAME; 20 mg/kg, iv) purchased from Sigma
Chemical Company (St. Louis, MO). Drugs were
dissolved in sterile saline and the pH was adjusted
to 7.4.
DataAnalysis: Mesenteric (MVC) and hindquar-
ter relative vascular conductance (HQVC) were cal-
culated by dividing the Doppler shift (Hz) by MAP
(mmHg). The maximal percent changes in MBF,
HQBF, MVC, HQVC and the area under the curve
(AUC) for the total change in MVC and HVC were
expressed as a percentage of control. Results are
presented as means ± SEM. The data were ana-
lyzed by one-way analysis of variance followed by
the Fisher LSD test. A value of p < 0.05 was con-
sidered to denote a signiﬁcant difference.
RESULTS
Cardiovascular adjustments induced by hy-
pothalamic stimulation (HS). In intact anes-
thetized rats electrical stimulation of the ventral
perifornical region of the hypothalamus (Figure 2)
elicited a pattern of cardiovascular adjustments
characterized by hypertension, tachycardia, in-
crease in hindquarter blood ﬂow (HQBF) and de-
crease in mesenteric blood ﬂow (MBF) (Figure 2A).
MAP and HR responses had a latency of 2 to 3 s,
peaked after 6 s and returned gradually to basal lev-
els after the end of the stimulation period. Blood
ﬂow responses had a longer latency (6 to 8 s) and
a much longer duration, remaining elevated up to
60 s after the onset of stimulation. The hindquarter
and mesenteric vascular conductances (HQVC and
MVC, respectively) were calculated as the blood
ﬂow/MAP ratio and expressed as percent of base-
line. As shown in Figure 3A, HS was associated
with a marked, long-lasting increase in HQVC in-
dicating active vasodilation. On the other hand, a
marked reduction of MVC was observed, indicating
visceral vasoconstriction (Figure 3B). Resting lev-
els and maximal changes during HS for all variables
are presented in Table I.
Effects ofα-Adrenoceptor blockade andbilateral
adrenalectomy on cardiovascular adjustments to
HS. According to Yardley and Hilton (Yardley and
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TABLE I
Effects of phentolamine, bilateral adrenalectomy and L-NAME




Basal (mmHg) 110 ± 2.9 94 ± 4.6a 119 ± 1.5ab
HS (, mmHg) 32 ± 3.4 33 ± 2.1 30 ± 5
HR
Basal (beats/min) 351 ± 11.4 360 ± 11.2a 292 ± 8.9ab
HS (, beats/min) 36 ± 5.6 48 ± 9.7 32 ± 7.5b
MBF
Basal (Hz) 6086 ± 554 4679 ± 439a 3848 ± 333ab
HS (% of control) −52 ± 2.6 −26 ± 5.3a −19 ± 6ab
MVC
Basal (Hz/mmHg) 55 ± 4.3 50 ± 4.3 32 ± 3ab
HS (% of control) −50 ± 3.5 −44 ± 4.9 −31 ± 6.1ab
HS (% AUC) 100 77 ± 15.8 31 ± 8.4b
HQBF
Basal (Hz) 3061 ± 243 2835 ± 231 1614 ± 165ab
HS (% of control) 132 ± 10.7 66 ± 7.4a 34 ± 5.2ab
HQVC
Basal (Hz/mmHg) 28 ± 2.3 31 ± 3.1 14 ± 1.4ab
HS (% of control) 169 ± 13 45 ± 9.4a 16 ± 4.2ab
HS (% AUC) 100 12 ± 2.8 3 ± 1b
Values are means ± SEM; n=8. Comparisons of effects of HS on mean arterial pressure (MAP), heart rate (HR),
mesenteric blood ﬂow (MBF), mesenteric vascular conductance (MVC), hind limbs blood ﬂow (HQBF), hind limbs
vascular conductance (HQVC) before (Control) and after phentolamine (1.5mg/kg, iv) plus bilateral adrenalectomy
and after phentolamine plus bilateral adrenalectomy plus L-NAME (20mg/kg, iv). a p < 0.05 compared to control,
b p < 0.05 compared to PHENT+ADREN.
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Fig. 2 – Changes in pulsatile arterial pressure (AP), hindquarter blood ﬂow (HQBF);
mesenteric blood ﬂow (MBF), mean arterial pressure (MAP) and heart rate (HR) produced
by hypothalamic stimulation (HS) (6 s trains, 1 ms square pulses, 100 Hz, 150µA), before
(A) and after phentolamine (1.5 mg/kg, iv) plus bilateral adrenalectomy (B) and after phen-
tolamine plus bilateral adrenalectomy plus L-NAME (20 mg/kg, iv) (C). Horizontal bars
represent the 6- s trains of electrical stimulation.
Hilton 1986, 1987), the muscle vasodilation pro-
duced by electrical stimulation of the hypothala-
mus in rats is due to a combination of reduction
of the sympathetic vasoconstrictor tone and activa-
tion of β2-adrenergic receptors by catecholamines
release. In the present study, after the cardiovas-
cular adjustments to HS had been established, the
animals received the α-receptor antagonist phento-
lamine (1.5 mg/kg, iv) and both adrenal glands
were removed. As shown in Figure 2B, 30 min af-
ter phentolamine plus bilateral adrenalectomy
MAP, MBF and HQBF were reduced, while HR
increased discretely. In this condition pressor and
tachycardic responses to HS were unaffected. Con-
versely, marked reductions in the magnitude and
duration ofHBF andMBF responseswere observed.
Therefore, themagnitude and duration of themesen-
teric vasoconstriction and the hindquarter vasodila-
tion were also reduced (Figure 3). However, it is
noteworthy that although a strong reduction of the
control response was observed the remaining va-
sodilation was substantial, consisting of an increase
in HQVC of 50% at its peak and 25 s of duration
(Figure 3A). The results obtained in this group of
experiments are summarized in Table I. Pressor and
tachycardic responses to HS after phentolamine +
adrenalectomy were similar to those observed in
the control. Maximal changes in MBF, HQBF and
HQVC were strongly reduced. When blood ﬂow
adjustments to HS were evaluated by the area of the
vascular conductance curves, a marked reduction in
hindquarter vasodilation was observed. Indeed, af-
ter phentolamine + adrenalectomy, the area under
the HQVC curve was reduced to 12% of that ob-
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Fig. 3 – Effects of HS on hindquarter vascular conductance (HQVC % of baseline) (A)
and mesenteric vascular conductance (MVC % of baseline) (B) before (square) and after
phentolamine (1.5 mg/kg, iv) plus bilateral adrenalectomy (PHENT+ADREN) (ﬁlled cir-
cles) and after phentolamine plus bilateral adrenalectomy plus L-NAME (20 mg/kg, iv) –
(PHENT+ADREN+L-NAME) (open circles).
served during the control period. Mesenteric vaso-
constriction to HS was also reduced after phento-
lamine + adrenalectomy though to a lesser extent.
Effects of L-NAME on hemodynamic responses
produced by HS in adrenalectomized animals
with α-adrenoceptor blockade. As previously de-
scribed, the combination of α-adrenoceptor block-
ade and bilateral adrenalectomy failed to abolish
muscle vasodilation induced by HS. These obser-
vations suggest that, besides the reduction of sym-
pathetic tone and the catecholamine release from
adrenal glands, another mechanism must participate
in this vasodilatory response. To test this hypothe-
sis, after phentolamine and bilateral removal of the
adrenal glands animals were treated with the NO
synthesis inhibitor L-NAME (20 mg/kg, iv). As
shown in Figure 2C, after L-NAME pulsatile ar-
terial pressure and MAP increased whereas basal
HR, HQBF and MBF levels were reduced. Pres-
sor and tachycardic responses to HS were not af-
fected. However, changes in HQBF and MBF were
severely reduced. Vascular conductance curves in-
dicate that after L-NAME hindquarter vasodilation
was reduced to a residual response whose onset was
no longer locked to HS (Figure 3A). Similarly,
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mesenteric vasoconstriction was greatly reduced in
magnitude and duration. The results obtained after
L-NAME in this group of experiments are summa-
rized in Table I.
Effects of L-NAME on the hemodynamic
responses produced by HS. The results obtained
in the previous group of experiments suggest that
release of NO may be a component of the mus-
cle vasodilation produced by HS. However, since in
those animals the muscle vasodilation had already
been greatly reduced by the combination of phen-
tolamine plus adrenalectomy, the magnitude of the
NO mechanism could not be properly evaluated. To
determine the role played by NO in these responses
we examined the cardiovascular adjustments to HS
before and after systemic administration of L-
NAME (20 mg/kg iv). As previously described, in
anesthetized rats HS produced hypertension, tachy-
cardia, hindquarter vasodilation and mesenteric
vasoconstriction (Figures 4A and 5). Thirtyminutes
after intravenous injection of L-NAME an increase
in the basalMAP values was observed, whereas HR,
MBFandHQBFwere decreased (Fig 4B).The fall in
MBF andHQBF resting levels was associatedwith a
decrease in vascular conductance in both territories.
The HS elicited rises in MAP and HR that were sim-
ilar to those observed during the control period. The
HQBF response to HS was markedly reduced both
in magnitude and duration. A distinct reduction in
MBF was still observed also when compared to the
control period.
L-NAME treatment reduced hindquarter va-
sodilation in magnitude and duration. As shown in
Figure 5A, after L-NAME the peak of HQVC was
reduced to approximately 50% and duration was
reduced to less than 20 s. After L-NAME this va-
sodilatory response was often followed by a long
period of reduced vascular conductance as depicted
in Figure 5A. The mesenteric vasoconstriction in-
duced by HS was not affected.
As shown in Table II, the intravenous injection
of the L-NAME produced a rise in MAP resting lev-
els while HR, MBF, MVC, HQBF and HQVC were
decreased. Pressor and tachycardic responses to HS
were not modiﬁed. Reductions in MBF and MVC
were not different from the control period. On the
other hand, the increase in HQBF was diminished.
Muscle vasodilation as indicated by the area under
theHQVCcurvewas reduced to 8%of that observed
during the control period.
Effects of α-adrenoceptor blockade and adrena-
lectomy on hemodynamic responses produced by
HS in animals with NO synthesis blockade. Af-
ter intravenous injection of L-NAME and analysis
of the cardiovascular adjustments to HS, the ani-
mals received phentolamine (1.5 g/kg, iv) and both
adrenal glands were removed. In this condition
blood pressure was reduced, while MBF was aug-
mented. HS induced hypertension and tachycar-
dia, but changes in HQBF and MBF were reduced
(Figure 4C). These reductions resulted in a smaller
hindquarter vasodilation and mesenteric vasocon-
striction (Figure 5). The results obtained in these
experiments are summarized in Table II.
DISCUSSION
The present results demonstrated that in anes-
thetized rats electrical stimulation of the hypotha-
lamus elicited the already well described pattern
of cardiovascular adjustments consisting of hyper-
tension, tachycardia, visceral vasoconstriction and
hindlimb vasodilation. Alpha-adrenergic blockade
plus bilateral adrenalectomy reduced, but did not
abolish, hindlimb vasodilation. The residual va-
sodilation was completely abolished after blockade
of NO synthesis by L-NAME. Similarly, when L-
NAME was administered to anesthetized animals,
vasodilation induced by hypothalamic stimulation
was profoundly reduced and the remaining response
was abolished by the combination of adrenergic
blockade plus adrenalectomy.
Histological analysis demonstrated that the
stimulation sites in this study were consistently
found in the perifornical area in the lateral hypotha-
lamus. These sites are inside the area previously
described by others as the hypothalamic defense
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TABLE II
Effects of L-NAME, phentolamine and bilateral adrenalectomy




Basal (mmHg) 109 ± 2.9 134 ± 4.5a 108 ± 7.7b
HS (, mmHg) 40 ± 3.1 31 ± 3.5 36 ± 5.3
HR
Basal (beats/min) 335 ± 16 276 ± 20a 319 ± 27.1a
HS (, beats/min) 37 ± 4.5 37 ± 10.2 53 ± 6.5
MBF
Basal (Hz) 7408 ± 712 4679 ± 551a 4769 ± 686a
HS (% of control) −71 ± 6.1 −66 ± 8.6 −50 ± 6.3ab
MVC
Basal (Hz/mmHg) 68 ± 7.2 35 ± 3.9a 44 ± 5.1a
HS (% of control) −75 ± 6.1 −72 ± 9 −59 ± 6.4a
HS (% AUC) 100 87 ± 11.7 39 ± 10b
HQBF
Basal (Hz) 3800 ± 199 1923 ± 169a 1753 ± 110a
HS (% of control) 150 ± 7 104 ± 21.9a 66 ± 16a
HQVC
Basal (Hz/mmHg) 35 ± 2.4 15 ± 1.4a 17 ± 1.7a
HS (% of control) 152 ± 7.8 85 ± 16.4a 34 ± 1.9a
HS (% AUC) 100 8 ± 2 3 ± 1.4b
Values are means ± SEM; n=8. Comparisons of effects of HS on mean arterial pressure (MAP), heart
rate (HR), mesenteric blood ﬂow (MBF), mesenteric vascular conductance (MVC), hind limbs blood ﬂow
(HQBF), hind limbs vascular conductance (HQVC) before (Control), after L-NAME (20 mg/kg, iv), and
after L-NAME plus phentolamine plus bilateral adrenalectomy (1.5 mg/kg, iv). a p < 0.05 compared to
control, b p < 0.05 compared to L-NAME.
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Fig. 4 – Changes in pulsatile arterial pressure (AP), hindquarter blood ﬂow (HQBF), mesen-
teric blood ﬂow (MBF), and mean arterial pressure (MAP) and heart rate (HR) produced by
hypothalamic stimulation (HS) (6-s trains, 1 ms square pulses, 100 Hz, 150µA), before (A),
after L-NAME (20 mg/kg, iv) (B) and after L-NAME plus phentolamine (1.5 mg/kg, iv) plus
bilateral adrenalectomy (C). Horizontal bars represent the 6-s trains of electrical stimulation.
area of the rat (Tan and Dampney 1983,Yardley and
Hilton 1986, 1987).
The pattern of cardiovascular adjustments ob-
served in the present study is also compatible with
previously described data (Kiely and Gordon 1994,
Yardley and Hilton 1987, Hilton and Zbrozyna
1963). This pattern is characterized by increases
in arterial blood pressure and heart rate. Cardiac
output is redistributed with distinctive decreases in
the mesenteric vascular conductance and a marked,
long-lasting increase in hindquarter vascular con-
ductance. It is accepted that the reduction in mesen-
teric vascular conductance is representative of
a general vasoconstriction in abdominal viscera,
whereas the increase in hindquarter vascular con-
ductance illustrates vasodilation of skeletal muscle
present in the hind and forelimbs.
After adrenergic blockade plus bilateral
adrenalectomy, a marked reduction in the magni-
tude and particularly in the duration of the vasodila-
tor response induced by hypothalamic stimulation
was observed. This result is compatible with previ-
ous studies on anesthetized rats (Yardley and Hilton
1987). According to these authors, the hindlimb
vasodilation induced by hypothalamic stimulation
comprises at least two major components: an ini-
tial, short response, due to reduction of sympathetic
vasoconstrictor tone, followed by a late, long-lasting
response due to the release of catecholamines that
act on β2-adrenergic receptors in the vasculature of
the skeletal muscle. It is noteworthy that adrenalec-
tomy and phentolamine alone had little effect on the
magnitude of the vasodilation. Bilateral adrenalec-
tomy seemed to reduce preferentially the dura-
tion of the response whereas α-adrenergic blockade
tended to increase the latency of the response. Sig-
niﬁcant reductions of the response were obtained
only after combined blockade of both components,
An Acad Bras Cienc (2005) 77 (2)















































Fig. 5 – Effects of HS on hindquarter vascular conductance (HQVC % of baseline) (A)
and mesenteric vascular conductance (MVC % of baseline) (B) before (square), after L-
NAME (20 mg/kg, iv) (ﬁlled circles) and after L-NAME plus phentolamine plus bilateral
adrenalectomy (open circles).
no matter the sequence of procedures performed.
However, as described in this study, signiﬁ-
cant vasodilator response remains after treatment
with phentolamine and adrenalectomy, suggesting
the presence of a yet another vasodilatormechanism.
Curiously, the existence of a unidentiﬁed va-
sodilator mechanism during defense reactions in the
rat has been acknowledge previously (Yardley and
Hilton 1987), but it was thought that the two already
described mechanisms account for the largest part
of the observed hindlimb vasodilation.
Lewis and colleagues suggested that release
of NO or NOFs may have contributed to defense-
related vasodilation. These investigators demon-
strated that air-jet stress in conscious rats produces
hindquarter vasodilation, which is markedly dimin-
ished by blockade of impulse propagation-mediated
release of neurotransmitters or by inhibition of NO
synthesis (Davisson et al. 1994). They also demon-
strated that postganglionic lumbar sympathetic
nerves innervating the hindlimb vasculature of the
rat contain NOS and that low-intensity electrical
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stimulation of the lumbar sympathetic chain pro-
duces a pronounced hindlimb vasodilation, which
is abolished by the administration of 7-nitroinda-
zole (7-NI), a speciﬁc inhibitor of neuronal NOS.
In addition, studies in cats demonstrated that fore-
limb and hindlimb vasodilation produced by hy-
pothalamic stimulation were greatly attenuated by
the inhibitor of nitric oxide synthesis, Nω-nitro-L-
arginine methyl ester (L-NAME) (Komine et al.
2003, Matsukawa et al. 1993).
The second component of vasodilation is more
persistent, and is due to release of catecholamines
into the circulation. Previous studies have suggested
that relaxation of vascular smooth muscle induced
by β2 receptor activation may involve synthesis of
NO andNO factors (Xu et al. 2000, Graves and Pos-
ton 1993, Gardiner et al. 1991). Previous studies
have also suggested that circulating catecholamines
may induce NO release by the endothelial cells
through activation of α1, α2 and β2 adrenergic re-
ceptors. Inhibition of NO synthesis by L-NAME
would block this component. Alternatively, it is
conceivable that reduction of the late stage vasodi-
lation is due to a L-NAME-induced reduction of
blood ﬂow to the adrenal gland, resulting in a re-
duced transport of catecholamines from the adrenal
medulla to its target tissues. The results obtained in
the present study after inhibition of NO synthesis by
L-NAME in animals pre-treated with phentolamine
and submitted to bilateral adrenalectomy are com-
patible with the hypothesis that NO mediates part
of the hindlimb vasodilation induced by hypothala-
mic stimulation.
To further conﬁrm these observations, in a sep-
arate group of animals the order of blockade was
inverted, and NO synthesis inhibition by L-NAME
preceded bilateral adrenalectomy and adrener-
gic blockade. Surprisingly, L-NAME treatment re-
sulted in a marked decrease in the magnitude and
duration of the hindlimb vasodilation induced by
hypothalamic stimulation. In fact, the area under
the curve of vascular conductance after L-NAME
was only 8% of that in control. This reduction was
comparable to that produced by the combination of
adrenergic blockade and adrenalectomy.
These results further support the hypothesis
that NO release is a critical component of the
hindlimb vasodilation induced by hypothalamic
stimulation. However, the extent of the reduction
in the vasodilator response after L-NAME demands
further consideration. The observation that L-
NAME reduced vasodilation by as much as 90%
of the control response suggests that, besides act-
ing on a putative nitrergic system, inhibition of NO
synthesis may also interfere with other vasodilator
mechanisms.
The initial component of vasodilation is pre-
sumably due to a withdrawal of sympathetic vaso-
constrictor drive. It is conceivable that the hyper-
tension induced by L-NAME activated the barore-
ceptors, resulting in sympatho-inhibition. If sym-
pathetic activity after L-NAME is low, it is not sur-
prising that hypothalamic stimulation had little
effect on this component.
The second component of vasodilation is more
persistent, and is due to release of catecholamines
into the circulation. Previous studies have suggested
that relaxation of vascular smooth muscle induced
by β2 receptor activation may involve synthesis of
NO andNO factors (Xu et al. 2000, Graves and Pos-
ton 1993, Gardiner et al. 1991). Previous studies
have also suggested that circulating catecholamines
may induce NO release by the endothelial cells
through activation of α1, α2 and β2 adrenergic
receptors. Inhibition of NO synthesis by L-NAME
would block this component. Alternatively, it
is conceivable that reduction of the late stage va-
sodilation is due to a L-NAME-induced reduction
of blood ﬂow to the adrenal gland, resulting in a re-
duced transport of catecholamines from the adrenal
medulla to its target tissues.
The results obtained in the present study sug-
gest a prominent role of NO in the muscle vasodila-
tion induced by stimulation of defense areas in the
rat hypothalamus. Whether NO arises from neu-
rotransmitters acting on endothelium cells or from
speciﬁc sympathetic post-ganglionic ﬁbers remains
to be determined.
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RESUMO
Em animais anestesiados a EE do hipotálamo produz um
padrão de ajustes cardiovasculares caracterizado por hi-
pertensão arterial, taquicardia, vasodilatação muscular e
vasoconstrição mesentérica, entretanto, os mecanismos
periféricos envolvidos nestes ajustes cardiovasculares
ainda não foram completamente esclarecidos. O presente
estudo teve como objetivo caracterizar os mecanismos pe-
riféricos responsáveis pela redistribuição de ﬂuxo sanguí-
neo produzidas pela EE do hipotálamo. Os resultados
obtidos demonstraram que 1) em ratos anestesiados a EE
do hipotálamo produziu hipertensão arterial, taquicardia,
vasoconstrição no leito mesentérico e acentuada vasodi-
latação dosmembros posteriores; 2) a combinação do blo-
queio farmacológico de receptores α1 e α2 adrenérgicos
com fentolamina mais adrenalectomia bilateral reduziu a
vasoconstrição mesentérica e a vasodilatação dos mem-
bros posteriores. Nestes animais o bloqueio da síntese
de NO com L-NAME provocou nova redução signiﬁcan-
te da vasodilatação dos membros posteriores; 3) a ad-
ministração de L-NAME, previamente o bloqueio farma-
cológico com fentolamina mais adrenalectomia bilateral,
reduziu as respostas de vasoconstrição mesentérica e de
vasodilatação dos membros posteriores. Estes resultados
sugerem a existência de pelo menos três possíveis me-
canismos responsáveis pela vasodilatação dos membros
posteriores induzida pela EE do hipotálamo: 1) ativação
de receptores β-adrenérgicos por catecolaminas liberadas
pela medula adrenal; 2) redução do tono vasoconstritor
simpático e 3) um terceiro mecanismo que utiliza NO
como mediador.
Palavras-chave: ﬂuxo sangüíneo dos membros posteri-
ores, hipotálamo, estimulação elétrica, reação de defesa.
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